NASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis $2.39 +0.30 (+14.35%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$2.40 +0.01 (+0.63%) As of 10/3/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Apyx Medical Stock (NASDAQ:APYX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Apyx Medical alerts:Sign Up Key Stats Today's Range$2.07▼$2.4050-Day Range$1.75▼$2.4252-Week Range$0.76▼$2.73Volume127,196 shsAverage Volume63,697 shsMarket Capitalization$90.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Apyx Medical (NASDAQ: APYX) is a medical device company focused on the development and commercialization of energy-based solutions for surgical and aesthetic applications. The company’s product portfolio includes devices that utilize radiofrequency energy, cold plasma and proprietary technologies designed to deliver precise thermal control and tissue treatment. Its key offerings encompass the J-Plasma technology under the Renuvion brand, which is primarily used for subdermal skin tightening and aesthetic procedures, and its portfolio of advanced energy medical devices for general surgery, gynecology and dermatology. Leveraging its dual focus on surgical and aesthetic markets, Apyx Medical serves physicians and healthcare providers across North America, Europe and select international regions. Its surgical devices are designed to enhance hemostasis, dissection and ablation in minimally invasive and open procedures, while its Renuvion system has gained adoption in cosmetic surgery for skin contraction and soft-tissue coagulation. The company supports its products with a combination of clinical training programs, customer service and collaborative research initiatives aimed at demonstrating safety and efficacy in various treatment settings. Established in early 2021 through a strategic combination of assets acquired from Bovie Medical, Apyx Medical has pursued a growth strategy centered on innovation and targeted commercial expansion. The company operates its headquarters in Clearwater, Florida, and maintains manufacturing and distribution capabilities to support an expanding global footprint. Guided by a leadership team with experience in medical technology and regulatory affairs, Apyx Medical continues to invest in product development and clinical evidence to broaden its treatment applications and enhance patient outcomes.AI Generated. May Contain Errors. Read More Apyx Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreAPYX MarketRank™: Apyx Medical scored higher than 21% of companies evaluated by MarketBeat, and ranked 853rd out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Apyx Medical.Read more about Apyx Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 6.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Apyx Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.73% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently increased by 1.51%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-1.07 Percentage of Shares Shorted0.73% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently increased by 1.51%, indicating that investor sentiment is decreasing. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Apyx Medical this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for APYX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Apyx Medical's insider trading history. Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APYX Stock News HeadlinesApyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025September 29, 2025 | finance.yahoo.comBTIG Sticks to Its Hold Rating for Apyx Medical (APYX)August 16, 2025 | theglobeandmail.comAI Continues to Surge—Here Are 2 Stocks Still Under $15Markets are volatile—but AI keeps rising. A new report reveals two under-the-radar AI stocks under $15 that could thrive in 2025’s uncertain market. These picks are backed by key trends most investors are missing.October 5 at 2:00 AM | Darwin (Ad)Apyx Medical Holds Annual Stockholders MeetingAugust 14, 2025 | msn.comApyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated GrowthAugust 8, 2025 | finance.yahoo.comApyx Medical Reports Q2 2025 Results and Raises GuidanceAugust 8, 2025 | msn.comApyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 | finance.yahoo.comApyx Medical outlines $50M–$52M 2025 revenue targets as AYON presales surpass expectations and China launch advancesAugust 8, 2025 | msn.comSee More Headlines APYX Stock Analysis - Frequently Asked Questions How have APYX shares performed this year? Apyx Medical's stock was trading at $1.58 at the start of the year. Since then, APYX stock has increased by 51.3% and is now trading at $2.39. How were Apyx Medical's earnings last quarter? Apyx Medical Corporation (NASDAQ:APYX) issued its quarterly earnings results on Thursday, August, 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.00. The business earned $11.37 million during the quarter, compared to the consensus estimate of $11.69 million. Apyx Medical had a negative trailing twelve-month return on equity of 158.22% and a negative net margin of 37.11%. Read the conference call transcript. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/07/2025Today10/05/2025Next Earnings (Estimated)11/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:APYX CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees270Year Founded1982Profitability EPS (Trailing Twelve Months)($0.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$23.46 million Net Margins-37.11% Pretax Margin-36.65% Return on Equity-158.22% Return on Assets-28.30% Debt Debt-to-Equity Ratio4.61 Current Ratio4.72 Quick Ratio3.95 Sales & Book Value Annual Sales$48.10 million Price / Sales1.88 Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book6.29Miscellaneous Outstanding Shares37,820,000Free Float32,071,000Market Cap$90.39 million OptionableOptionable Beta1.46 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:APYX) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.